Moderna was down in Tuesday trading after a bearish call from BofA Securities sent shares lower. Analysts led by Tim Anderson relaunched coverage of 11 large-cap U.S. pharma and biotech names in a ...

https://www.tipranks.com/news/the-fly/anavex-price-target-raised-to-42-from-40-at-h-c-wainwright BofA reinstated coverage of Moderna (MRNA) with an Underperform ...

Moderna Inc (MRNA) stock saw a modest uptick, ending the day at $41.58 which represents a slight increase of $2.20 or 5.59% from the prior close of $39.38. The stock opened at $39.71 and touched a low ...

For Moderna (MRNA), BofA noted “it was a tough time to be a vaccine company,” even if Robert F. Kennedy Jr. doesn’t become head of the Department of Health and Human Services. It added that ...

Moderna Inc (MRNA) stock saw a decline, ending the day at $40.13 which represents a decrease of $-0.30 or -0.74% from the prior close of $40.43. The stock opened at $40.35 and touched a low of $39.79 ...

Moderna (MRNA) shares tumble after Bank of America analysts reinstated its Underperform rating for the stock. In a broader note about the pharmaceutical and biotech spaces, Bank of America's team ...

BofA reinstated coverage of Moderna (MRNA) with an Underperform rating and $41 price target calling it “a tough time to be a vaccines company,” citing COVID revenue stream uncertainty even if ...

Analysts issued an Underperform rating for shares while reluanching coverage of large-cap U.S. pharma and biotech names. Warren Buffett tells people to buy an S&P 500 index fund. A celebrity tech ...

Moderna (MRNA) shares tumble after Bank of America analysts reinstated its Underperform rating for the stock. In a broader note about the pharmaceutical and biotech spaces, Bank of America's team it's ...